Discovery of potent HIV-1 protease inhibitors incorporating sulfoximine functionality

被引:39
作者
Lu, Ding
Vince, Robert
机构
[1] Univ Minnesota, Coll Pharm, Dept Med Chem, Minneapolis, MN 55455 USA
[2] Univ Minnesota, Acad Hlth Ctr, Ctr Drug Design, Minneapolis, MN 55455 USA
关键词
HIV-1 protease inhibitor; C-2; symmetry; sulfoximine; transition state mimic;
D O I
10.1016/j.bmcl.2007.07.095
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Based on the unique property of sulfoximine and the homodimeric Q structural symmetry of HIV-1 protease, a novel class of sulfoximine-based pseudosymmetric HIV-1 protease inhibitors was designed and synthesized. The sulfoximine moiety was demonstrated to be important for HIV-1 protease inhibitor potency. The most active stereoisomer (2S,2 ' S) displays a potency of 2.5 nM (IC50) against HIV-1 protease and an anti-HIV-1 activity of 408 nM (IC50). A possible mode of action is proposed. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5614 / 5619
页数:6
相关论文
共 21 条
  • [21] Rapid discovery and structure-activity profiling of novel inhibitors of human immunodeficiency virus type 1 protease enabled by the copper(I)-catalyzed synthesis of 1,2,3-triazoles and their further functionalization
    Whiting, Matthew
    Tripp, Jonathan C.
    Lin, Ying-Chuan
    Lindstrom, William
    Olson, Arthur J.
    Elder, John H.
    Sharpless, K. Barry
    Fokin, Valery V.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (26) : 7697 - 7710